Aurélien FAUVEL

Sales/succession: Are you exit ready? Company sales and succession options are more important today than ever. Unlike a few years ago, buyers expect to find a well-founded exit readiness in the target company. With Pulsar Consultong assessment tool, you get: ✅ Precise company valuation ✅ Qualitative pre-due diligence

2

MP founding partner, Roman Göd, recently joined the FINANCE Think Tank Corporate Banking & Finance – Eine Initiative der Targecy GmbH podcast What's up, Corporate Finance? to discuss findings from our latest MP industrial Private Equity (MPiPE) Indicator. He shared valuable insights into the shifting dynamics of European private equity firms, highlighting renewed interest in investing in industrial companies and a cautiously optimistic mood in the DACH region. Listen to the full episode for in-depth analysis of the developments shaping the private equity landscape in the coming months.   #MP #mergersandacquisitions #privateequity #corporatefinance #investmentbanking #pe #industrialsector #marketoutlook #privateequitytrends #fundraising #survey #insights #privateequity #investments #europe #podcast 

15

At times when innovation in MedTech can directly impact patient care and outcomes, finding the right leaders is critical. In the latest blog post, our Executive Search Consultant Priya Schrenk explains the key benefits of prioritising quality over quantity in candidate selection. Read more via the link below: 📲

11

I had a blast at health.tech conference together my dear colleague Robert Huber representing Digital Dental & Healthcare Technology GmbH & Co. KG. We are building innovative dental medical devices and wanted to identify key partners, industry stakeholders, and hot trends in this sector. For me it was a success. Thanks to everyone we met. Here are three fast take-aways: #hardware is becoming more and more of a hot topic. Who would have thought? #fundraising from VCs is tough right now but there are other options of financing like getting public grants or even starting an equity crowdfunding campaign - a hot trend in the US right now. #startup life is like deep sea diving. You get the oxygen tank (cash) you dive in and from then on the clock starts ticking (burn rate) and you know you'll need to resurface (raise again/survive on your own) in the near future. Special thanks to Robert, it was a great event with you. Let's keep innovating. #medical #device #startup

34

4 Kommentare

This week, BILANZ Wirtschaftsmagazin published its annual ranking of the “richest 100 under 40”, and I am one of them. Thank you very much! Yes, I am not yet 40 years old and yes, I have managed to raise 12.2 million Swiss francs in venture capital so far. However, I must clarify: These millions are not in my personal bank account. Even though this money is not mine, I feel honored because it gives me the opportunity to bring our vision into focus and raise awareness for women’s health. Women’s health has been neglected for years and is now becoming an important societal issue. Yet, it is still inadequately funded and researched. I am proud to be part of this growing industry with Pregnolia and to be able to drive it forward. For many years now, I have been passionate about the topic of Women's Health, especially in pregnancy care. Preterm birth is one of the biggest challenges in modern obstetrics. Since 2017, Pregnolia AG has been actively striving to improve preterm birth diagnostics and working every day to bring our solution into daily clinical practice. Our goal is to help millions of mothers and their babies around the world. We are always looking for investors who share our vision and want to support us on our journey. So, let’s join forces to raise awareness for women's health and especially preterm birth, and work towards a world where every pregnancy goes to full term. If you would like to learn more about Pregnolia and our ongoing financing round, contact me! #financing #pretermbirth

351

41 Kommentare

#AI and #Biotech Disruptions: #Startups Redefining Health and Fitness Solutions 🎯 1️⃣ Refoxy Pharma Raises €9.1M Lead Investor: Boehringer Ingelheim Venture Fund With participation from: Apollo Health Ventures, NRW.BANK, HTGF | High-Tech Gründerfonds 🔗 Read more: https://lnkd.in/gp2Pr-xA 📍 Berlin, Germany ------------------------------------------------------------------------------------ 2️⃣ GROWL Secures $4.75M Lead Investor: Skip Capital With participation from: Kima Ventures, Teampact.ventures, Ciryl Gane, and others 🔗 Learn more: https://lnkd.in/gSvhhQFv 📍 Austin, Texas #FundingNews #SeedFunding #HealthTech #zefyron #startupdatabase

5

🏥 𝗞𝗿𝗮𝗻𝗸𝗲𝗻𝗵𝗮𝘂𝘀𝗿𝗲𝗳𝗼𝗿𝗺 𝟮𝟬𝟮𝟰: 𝗔 𝗚𝗮𝗺𝗲 𝗖𝗵𝗮𝗻𝗴𝗲𝗿 𝗳𝗼𝗿 𝗚𝗲𝗿𝗺𝗮𝗻 𝗛𝗲𝗮𝗹𝘁𝗵𝗰𝗮𝗿𝗲 🚑 On November 22, 2024, the Krankenhausreform passed the Bundesrat, setting the stage for improved hospital care and strengthening access to healthcare across Germany. This landmark reform is not only a win for patients but also a wake-up call for the healthcare industry to embrace digital transformation. 🙏 A huge thank you to the team at Roland Berger - your “𝗞𝗿𝗮𝗻𝗸𝗲𝗻𝗵𝗮𝘂𝘀 𝗜𝗧-𝗠𝗼𝗻𝗶𝘁𝗼𝗿 𝟮𝟬𝟮𝟰” offers incredible insights into how digital transformation is reshaping our healthcare landscape. This report couldn’t have come at a better time. 💡 Key Insights from Roland Berger’s “Krankenhaus IT-Monitor 2024”: ⚫ 𝗣𝗮𝘁𝗶𝗲𝗻𝘁 𝗣𝗼𝗿𝘁𝗮𝗹𝘀: 53% of hospitals now use digital patient portals, yet adoption remains underwhelming due to insufficient training and marketing efforts. ⚫ 𝗧𝗲𝗹𝗲𝗺𝗮𝘁𝗶𝗰𝘀 𝗜𝗻𝗳𝗿𝗮𝘀𝘁𝗿𝘂𝗰𝘁𝘂𝗿𝗲: Solutions like ePrescriptions are underutilized, highlighting the need for user-centric designs and interoperability. ⚫ 𝗡𝗲𝘁𝘄𝗼𝗿𝗸𝗶𝗻𝗴 𝗶𝗻 𝗛𝗲𝗮𝗹𝘁𝗵𝗰𝗮𝗿𝗲: 75% of hospitals engage in intersectoral networks, leveraging digital tools like virtual tumor boards for collaboration. ⚫ 𝗜𝗻𝘁𝗲𝗿𝗼𝗽𝗲𝗿𝗮𝗯𝗶𝗹𝗶𝘁𝘆 𝗚𝗮𝗽𝘀: Many hospitals struggle with siloed systems and lack of standardized data, driving up costs and limiting efficiency. 🤔 𝗪𝗵𝗮𝘁 𝗗𝗼𝗲𝘀 𝗧𝗵𝗶𝘀 𝗠𝗲𝗮𝗻 𝗳𝗼𝗿 𝗖𝗘𝗢𝘀 & 𝗜𝗻𝘃𝗲𝘀𝘁𝗼𝗿𝘀? The Krankenhausreform and the growing digitization of healthcare present a unique opportunity for M&A. The rise of specialized providers and the shift from monolithic systems create room for strategic investments. Companies offering interoperability solutions, data governance, and scalable IT infrastructures are poised to become key players. As a tech investment banker and founder of DoctorBox, I’m passionate about how these shifts will redefine the future of healthcare. My focus is on identifying the HealthTech innovators driving this change and creating value for stakeholders.

22

🏆 Qualiwise Wins 2nd Place at the Munich Business Plan Competition 🏆 🚀 What an incredible journey! This week, the grand finale of BayStartUP's Munich Business Plan Competition took place in the heart of Munich. The competition spanned the entire year and culminated in a fantastic award ceremony with over 200 network partners coming together to announce this year's winners from more than 220 startup applications. 🎉Qualiwise is proud and grateful to announce that we secured 2nd place with our AI-driven B2B SaaS solution for digitized product quality inspections. This award once again highlights the immense potential in our unique business niche, our product maturity, and our robust company planning. 👏 Special congratulations to EpiCure (the cancer killer) for winning 1st prize and AUDAVIS for securing 3rd prize. Your achievements are truly well-deserved. 🙏 A big THANK YOU goes out to the brilliant BayStartUP organization team, who have perfected these competitions over more than 20 years, greatly boosting the Bavarian startup ecosystem as a whole. We also extend our gratitude to the Bayerisches Staatsministerium für Wirtschaft, Landesentwicklung und Energie, Investors, coaches and especially to all our business partners. Your support and input have been invaluable in driving innovation and finding smart solutions for the archaic supplier collaboration we see today. Stay tuned for more updates, and follow us to keep up with our journey! 🚀 #MunichBusinessPlanCompetition #BayStartUP #Startup #SaaS #QualityInspections #SupplierQuality #Paperless #ZeroIncomingInspection #BavarianStartups

64

19 Kommentare

𝗜𝗻 𝗦𝘄𝗶𝘁𝘇𝗲𝗿𝗹𝗮𝗻𝗱, 𝘄𝗲 𝗮𝗿𝗲 𝗻𝗼𝘁 𝗶𝗻𝘁𝗲𝗿𝗲𝘀𝘁𝗲𝗱 𝗶𝗻 𝗽𝗮𝘁𝗶𝗲𝗻𝘁 𝘁𝗵𝗲𝗿𝗮𝗽𝗶𝗲 𝗱𝗮𝘁𝗮? We prefer to buy commercial data and decide on this basis what is right for the patient. Of course, commercial data is easier to obtain. Anyone can do that today. A pack costs CHF 67.35. The patient has bought it. So it is considered taken? Wrong. This is pure metrics. On the other hand, you can't buy the opinions and behaviour of patients 1:1 in data shops. Life is not arithmetic. Unfortunately, it is a fact that 95% of all therapy data comes from patient behaviour at home. Not from the doctor's dispensing, the pharmacy or the cash register. We should face up to the fact that the gold standard is the best, but unfortunately often does not correspond to the desired reality, when it comes to real-world-patient-data (RWPD). This means that all those who draw their conclusions from this data are actually only looking at +/- 5% of patient behaviour in relation to medication. Isn't that kind of frightening? Shouldn't we rethink the focus of our thinking when it comes to medication use? Patient-centredness should no longer be misused as a buzzword. I am in favour of a stronger focus on data on the actual patient outcome. Redcare Pharmacy pharmaSuisse - Schweizerischer Apothekerverband santésuisse Galenica Sanitas Krankenversicherung eHealth Suisse #HealthcareInnovation #PatientCentricity #RealWorldEvidence #Pharma #PatientData #DigitalHealth #HealthcareData #PatientInsights #TherapyData #MedTech #HealthTech #DataScience #PatientEngagement #HealthCareRevolution #ClinicalData

17

1 Kommentar

I truly look forward to providing part of this webinar where I will focus on EU and US requirements concerning Combination Products. Thanks a lot to Grace for organizing this! #confinis #combinationproducts #article117 #regulatory #andbeyond

24

1 Kommentar

Finanzplatz Frankfurt am Main --- FAMILY OFFICES & RESEARCH - The Top 10 Family Office Trends, 2024: "Deloitte Private’s inaugural Family Office Insights Series – Global Edition dives deep into the top 10 family office trends of 2024, covering important topics such as investing, risk management, sustainability, hiring, succession planning, cybersecurity, technology transformation, and more. This comprehensive report is informed by a global survey of 354 single family offices and 40 in-depth interviews with senior family office executives. The families represented hold an average wealth of US$3.8 billion and total estimated wealth of US$1.3 trillion, while the family offices have an average assets under management (AUM) of US$2.0 billion and total estimated AUM of over US$700 billion.  This report has been designed to deliver an interactive experience which is accessible when opened in Adobe Acrobat and the report is downloaded to your computer." (QUOTE - Deloitte - FAMILY OFFFICES & CENTER OF COMPETENCE: Dr. Rebecca Gooch, Adrian Batty, Wolfe Tone Sandra van Buren Cindy van de Luijtgaarden - www.deloitte.com) FAMILY OFFICE INSIGHTS SERIES & TOPICS:   1. Growth projected despite uncertain times 2. Eyes on risk management 3. Private equity climbs to the top 4.  Europe’s focus on sustainable investing heats up, while North America’s cools 5. Family offices are hiring and looking to further professionalize 6. Outsourcing to scale up 7. Jumping on the tech train 8. Tackling cyberthreats 9. Charting a path to succession 10. As confidence lacks in the next generation, focus turns to training LINK: FAMILY OFFICE INSIGHTS SERIES -  The Top 10 Family Office Trends: Executive Summary 2024: https://lnkd.in/e9TS3jFJ Finanzplatz Schweiz Finanzplatz Liechtenstein FINANZPLATZ ÖSTERREICH Finanzplatz Deutschland Private Label Fonds FUND BOUTIQUES CAT BONDS INVESTING IN INDIA --- #familyoffice #familyoffices #assetmanagement #assetallocation

56

4 Kommentare

Bits & Pretzels HealthTech, now known as health.tech conference, is always a very special time in Munich. Over 2,500 healthcare executives and investors come together to mingle about the latest trends and innovation in this space. This year, I am especially excited about the event, having the pleasure to moderate the Digital Twin Panel! If you’re passionate about the future of healthcare, you won’t want to miss this. We’ve got an incredible lineup of experts ready to dive into how digital twin technology can lead us into a new era of precision medicine and improved patient outcomes: Dr. Janina Beilner (SVP Healthcare Market, Siemens), Jens Dommel (Head of Healthcare EMEA, Amazon Web Services (AWS), Matthias Patz (Chief Innovation Officer, BIOTRONIK), and Enrique Morales Orcajo, PhD (Simulation Lead, Ambu A/S). Looking forward to seeing many known faces in Munich and also to get to know new ones. Let’s get inspired and envision the next frontier together! Dr. Cihat Cengiz Simon Kreitmair Manuel Opitz Camilla Steinhart Federico Acosta Amy K. Fabian Scheugenpflug Reto Näscher Markus Rommel Kurt Höller Jochen Hurlebaus Beatus Buchzik Robert Thielicke Dr. Stefan Braunewell Bjoern Eskofier Stefan Raith Christian Johner Martin Müller Sandrine Egron Eckhardt Weber Stefanie Brandl Valentine Gesche Joy Cürten and many more #HealthTech #DigitalTwins #HealthcareInnovation #PrecisionMedicine #HealthTechConference #HT24 #FutureOfHealthcare #DigitalTransformation #MedicalTechnology

119

17 Kommentare

𝗧𝗵𝗲 𝗣𝗼𝘄𝗲𝗿 𝗼𝗳 𝗩𝗶𝘀𝗶𝗼𝗻 𝗶𝗻 𝗧𝗶𝗺𝗲𝘀 𝗼𝗳 𝗖𝗿𝗶𝘀𝗶𝘀 🏹  Germany is facing a crisis: a declining economy, mass layoffs, and low confidence—largely self-inflicted. Investment is low, regulation is high, and decisive action on digitalisation is lacking. Three rival consulting giants #McKinsey, #BCG and #RolandBerger just did something unprecedented: They joined forces to craft a vision for Germany's future called Agenda 2035. This isn’t just a strategy—it’s a blueprint for #leadership in times of crisis. Typically, a #vision starts with an assessment of the current situation, followed by the definition of a goal and a mission statement. in other words: ✅ Where do we want to go? ✅ What do we stand for? ✅ What do we do and why? Their response in the Agenda 2023 is surprisingly straightforward: ➡️ Strengthen 4 core industries (Mechanical engineering, the automotive industry, the chemical and pharmaceutical industry, information technology, as well as the steel and metal production sectors.) ➡️ Develop 4 future sectors (AI, green tech, health tech, mobility). What makes this agenda remarkable is how it delivers lessons for all leaders for crafting a vision: 1️⃣ Focus: The agenda balances ambition with clear priorities, targeting what matters most for sustainable growth. 2️⃣ Collaboration over Competition: Rival firms united to solve a national crisis—a testament to the power of shared vision. 3️⃣ Vision Backed by Action: It doesn’t stop at ideas. Agenda 2035 includes actionable plans, measurable goals, and timelines. The key takeaway? A strong vision inspires action. Whether you’re leading a country or a company, the formula is the same: Set bold goals. Build partnerships. Execute relentlessly. Germany’s crisis is serious, but so the opportunity to rise is stronger. The time for action is now. PS At the Startup-Verband, we know the power of clear vision. That’s why we developed the Innovation Agenda 2030—a plan to make Germany a leader in digital transformation ➡️ https://lnkd.in/dsYXQchH #Leadership #Vision #Innovation #GermanEconomy #Agenda2035

24

13 Kommentare

Germany's startup ecosystem is a powerhouse waiting to fully unleash its potential in driving digital and sustainable transformation. But how do we make sure this happens? The Startup-Verband, the voice of German startups, addresses this head-on with their bold new initiative, "Innovationsagenda 2030: Weltklasse Made in Germany" (link in comments). Here’s what resonates most with me: 🚀 A Regulatory Framework Built for the Future To foster real innovation, we need policies that allow startups to experiment, iterate, and scale swiftly. Flexible, forward-thinking regulations in areas like AI and Climate Tech could be the catalyst for Germany’s long-term global leadership. 🌟 Stronger Leadership & Collaboration The future of innovation depends on tighter collaboration between government, industry, and startups. Building partnerships that connect research with industry can ignite sustainable growth and cement Germany’s place as a global innovation hub. 💬 What do you think is the most crucial next step in shaping Germany's innovation landscape? Let’s discuss in the comments below! #Innovationsagenda2030 #Startups #DigitalTransformation #Germany2030

82

6 Kommentare

https://lnkd.in/emRQNxz7 An insightful article by Winand von Petersdorff-Campen in FAZ discusses why America is outpacing Europe economically. The key takeaway: America's dynamic labor market and productivity gains have been vital for its quicker recovery. This reinforces our perspective in Real Estate Investment & Development, where we observe a disparate development favoring the American market due to significantly stronger demand drivers. This trend aligns with our strategic focus and bolsters our growth prospects in the U.S. By the end of last year, the U.S. had fully recovered from the pandemic, while the Eurozone's GDP was 5% below trend, the UK was 6% behind, and Canada was 4% behind. Alarmingly, growth trends in Europe and Canada have weakened, suggesting these economies may never fully recover from the pandemic's impact. Here are the main points: U.S. Economic Outperformance: America has recovered from the pandemic faster than most industrial nations, including Germany. Key Difference: Higher productivity and longer working hours by American workers. Federal Reserve Study Insights: o  Traditional factors like government spending explain differences only partially. o  U.S. avoided deep recession due to a dynamic labor market, unlike Europe which used measures like short-time work to keep unemployment low initially. o  Europe's rigid employment policies hindered adaptation to new economic conditions. o  U.S. saw a surge in new business formations post-pandemic, while Europe lagged. Central Bank Policies: Although central banks in the U.S. and Europe raised interest rates nearly simultaneously since 2022, the impact varied. In the U.S., higher rates didn't affect many citizens and businesses due to fixed-rate mortgages and loans, and a lower reliance on bank credit. In contrast, Canadians and Europeans felt the impact more, yet this still doesn't fully explain the growth gap. Policy Impacts: The Ukraine war and slow EU funding approval impacted Europe more severely.  

11

2 Kommentare

Is it time to upgrade your finances? Check out our financial performance review! #cfo #cfoservice #fiancecheck

6

Beirat für Startups #34 Ein Beirat kann grundsätzlich für Startups von großem Vorteil sein. Wie immer, ist es eine Entscheidung, in der es auf den Einzelfall ankommt. 🛣 Einige Gründe hierzu behandele ich wöchentlich in meiner Beitragsreihe : Zum letzten Post der Reihe: https://lnkd.in/dfQsdEuf The Benefits of a Biotech Advisory Board 🧪🔬 As a leader in the biotech industry, I'm excited to share the advantages of having a strong advisory board with expertise in biotechnology. 💡 Cutting-Edge Insights 🔍 An advisory board composed of seasoned biotech professionals can provide invaluable, up-to-date insights into the latest industry trends, technological advancements, and regulatory changes. Their deep knowledge and experience can help guide your strategic decision-making and ensure your company stays ahead of the curve. 🧠 Specialized Expertise 🔬 Biotech advisory board members bring a wealth of specialized expertise across various disciplines, such as drug development, clinical trials, regulatory affairs, and commercialization. Their diverse backgrounds can help you navigate the complex and ever-evolving biotech landscape more effectively, ultimately driving your company's success. 🧪 Networking and Connections 🤝 A well-connected biotech advisory board can open doors to new partnerships, collaborations, and funding opportunities. Their extensive industry networks can introduce you to key stakeholders, potential investors, and strategic partners, expanding your reach and unlocking new avenues for growth. 🌐 Credibility and Validation 👍 Having respected biotech experts on your advisory board can significantly boost your company's credibility and validation in the eyes of investors, regulatory bodies, and potential partners. This can be particularly valuable when seeking funding, navigating the regulatory landscape, or engaging with industry leaders. 🏆 Objective Guidance 🧭 An advisory board provides an outside perspective and objective guidance, which can be invaluable in navigating complex business decisions. Their impartial insights can help you identify blind spots, mitigate risks, and make more informed choices that align with your company's long-term goals. 🧠 By leveraging the expertise and experience of a biotech advisory board, you can unlock a competitive edge, drive innovation, and accelerate your company's growth in the dynamic biotech industry. 🚀 #advisoryboard #board #scaleup

22